Accuray reported a solid start to fiscal year 2021 with net revenue of $85.3 million and operating income of $5.5 million. Adjusted EBITDA grew to $9 million, and the ending backlog increased by 21 percent from the previous year.
Net revenue reached $85.3 million, with an operating income of $5.5 million.
Adjusted EBITDA increased to $9 million from a loss of $1 million in the prior year's first quarter.
Gross orders totaled $50.5 million, while the order backlog ended at $597.3 million, a 21% increase year-over-year.
The company expects revenue recognition for China Type A systems to begin in the second quarter of fiscal 2021.
Due to the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry, Accuray believes it is prudent to refrain from providing financial guidance for fiscal year 2021.
Visualization of income flow from segment revenue to net income